The Role of Pretreatment FDG-PET in Treating Cervical Cancer Patients With Enlarged Pelvic Lymph Node(s) Shown on MRI: A Phase 3 Randomized Trial With Long-Term Follow-Up.

[1]  John O. Prior,et al.  The role of PET/CT in cervical cancer , 2013, Front. Oncol..

[2]  T. Yen,et al.  Molecular imaging in the management of cervical cancer. , 2012, Journal of the Formosan Medical Association = Taiwan yi zhi.

[3]  Young Seok Kim,et al.  Risk assessment model for overall survival in patients with locally advanced cervical cancer treated with definitive concurrent chemoradiotherapy. , 2012, Gynecologic oncology.

[4]  M. Irahara,et al.  Adjuvant chemotherapy following concurrent chemoradiotherapy for uterine cervical cancer with lymphadenopathy. , 2012, Oncology letters.

[5]  A. Bats,et al.  Accuracy of 18-Fluoro-2-deoxy-d-glucose Positron Emission Tomography in the Pretherapeutic Detection of Occult Para-aortic Node Involvement in Patients with a Locally Advanced Cervical Carcinoma , 2011, Annals of Surgical Oncology.

[6]  P. Grigsby,et al.  Lymph node staging by positron emission tomography in cervical cancer: relationship to prognosis. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  T. Yen,et al.  Surgical and radiologic staging of cervical cancer , 2010, Current opinion in obstetrics & gynecology.

[8]  T. Yen,et al.  A prospective randomized trial to study the impact of pretreatment FDG-PET for cervical cancer patients with MRI-detected positive pelvic but negative para-aortic lymphadenopathy. , 2010, International journal of radiation oncology, biology, physics.

[9]  Wei-Chun Chang,et al.  Risk stratification for failure in patients with advanced cervical cancer after concurrent chemoradiotherapy: another way to optimise treatment results. , 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

[10]  T. Yen,et al.  Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases. , 2008, Gynecologic oncology.

[11]  Stephen W Lagakos,et al.  Statistics in medicine--reporting of subgroup analyses in clinical trials. , 2007, The New England journal of medicine.

[12]  David M Kent,et al.  Limitations of applying summary results of clinical trials to individual patients: the need for risk stratification. , 2007, JAMA.

[13]  B. Erickson,et al.  Extended-field irradiation and intracavitary brachytherapy combined with cisplatin chemotherapy for cervical cancer with positive para-aortic or high common iliac lymph nodes: results of ARM 1 of RTOG 0116. , 2007, International journal of radiation oncology, biology, physics.

[14]  C. Ottosen,et al.  The diagnostic value of PET/CT scanning in patients with cervical cancer: a prospective study. , 2007, Gynecologic oncology.

[15]  Seok-ki Kim,et al.  Comparison of the accuracy of magnetic resonance imaging and positron emission tomography/computed tomography in the presurgical detection of lymph node metastases in patients with uterine cervical carcinoma , 2006, Cancer.

[16]  Chun-Chieh Wang,et al.  Risk stratification of patients with advanced squamous cell carcinoma of cervix treated by radiotherapy alone. , 2005, International journal of radiation oncology, biology, physics.

[17]  P. Rothwell.  Subgroup analysis in randomised controlled trials: importance, indications, and interpretation , 2005, The Lancet.

[18]  P. Grigsby,et al.  Lymph node control in cervical cancer. , 2004, International journal of radiation oncology, biology, physics.

[19]  T. Yen,et al.  Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT. , 2004, International journal of radiation oncology, biology, physics.

[20]  Mitchell Morris,et al.  Pelvic irradiation with concurrent chemotherapy versus pelvic and para-aortic irradiation for high-risk cervical cancer: an update of radiation therapy oncology group trial (RTOG) 90-01. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[21]  Y. Hung,et al.  Usefulness of (18)F-fluorodeoxyglucose positron emission tomography to detect para-aortic lymph nodal metastasis in advanced cervical cancer with negative computed tomography findings. , 2003, Gynecologic oncology.

[22]  K. Ng,et al.  Isolated paraaortic lymph node recurrence after definitive irradiation for cervical carcinoma. , 2001, International journal of radiation oncology, biology, physics.

[23]  F Dehdashti,et al.  Lymph node staging by positron emission tomography in patients with carcinoma of the cervix. , 2001, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[24]  M. Mix,et al.  Metastatic lymph nodes in patients with cervical cancer: detection with MR imaging and FDG PET. , 2001, Radiology.

[25]  P J Eifel,et al.  Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer. , 1999, The New England journal of medicine.

[26]  J. Hong,et al.  The prognostic significance of pre- and posttreatment SCC levels in patients with squamous cell carcinoma of the cervix treated by radiotherapy. , 1998, International journal of radiation oncology, biology, physics.

[27]  T. Inoue,et al.  Prophylactic irradiation of para-aortic lymph nodes in carcinoma of the uterine cervix. A prospective randomized study. , 1995, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].

[28]  P. Grigsby,et al.  Prophylactic Extended-Field Irradiation of Para-aortic Lymph Nodes in Stages IIB and Bulky IB and IIA Cervical Carcinomas: Ten-Year Treatment Results of RTOG 79-20 , 1995 .

[29]  P. Disaia,et al.  Carcinoma of the cervix treated with radiation therapy I. A multi‐variate analysis of prognostic variables in the gynecologic oncology group , 1991, Cancer.

[30]  A. Gerbaulet,et al.  Is prophylactic para-aortic irradiation worthwhile in the treatment of advanced cervical carcinoma? Results of a controlled clinical trial of the EORTC radiotherapy group. , 1988, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.